Document is current
Any future updates will be listed below
-
Authors
Nastoupil, Loretta J. https://orcid.org/0000-0001-6071-8610
- License Information
-
More Information
Article History
First Online: 5 February 2026
Competing interests
: L.J.N. has received honoraria for participation in advisory boards from AstraZeneca, BMS, Genentech, Genmab, Johnson & Johnson, Novartis and Regeneron; and served as principal investigator for the CELESTIMO trial.
